Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Heart Rhythm. 2021 Jan 26;18(5):709–716. doi: 10.1016/j.hrthm.2021.01.021

Table 1.

Baseline Characteristics of the study population, stratified by baseline HF status.

Overall HF No HF P-value
N=39,710 N=25,054 N=14,656
Age, years [mean(SD)] 77.1(8.7) 76.3(8.9) 78.5(8.0) <.001
Male 24,119(60.7) 16,245(64.8) 7,874(53.7) <.001
Race/ethnicity <.001
 White 36,710(92.4) 22,848(91.2) 13,862(94.6)
 Black 1,997(5.0) 1,568(6.3) 429(2.9)
 Other 319(0.8) 198(0.8) 121(0.8)
Device Voltage <.001
 Low Voltage(pacemaker) 20,156(50.8) 8,248(32.9) 11,908(81.3)
 High Voltage(defibrillator) 19,554(49.2) 16,806(67.1) 2,748(18.8)
Device Type <.001
 Dual Chamber Pacemaker 17,797(44.8) 6,417(25.6) 11,380(77.6)
 CRT-P 2,359(5.9) 1,831(7.3) 528(3.6)
 Dual Chamber ICD 7,750(19.5) 5,715(22.8) 2,035(13.9)
 CRT-D 11,804(29.7) 11,091(44.3) 713(4.9)
Comorbid conditions
 Dementia 1,328(3.3) 822(3.3) 506(3.5) .36
 Diabetes Mellitus 15,366(38.7) 11,258(44.9) 4,108(28.0) <.001
 Ischemic heart disease 28,654(72.2) 20,606(82.2) 8,048(54.9) <.001
 Peripheral vascular disease 9,132(23.0) 6,727(26.9) 2,405(16.4) <.001
 Congestive Heart failure 25,054(63.1) 25,054(100) 0 -
 Cerebrovascular disease 7,028(17.7) 4,643(18.5) 2,385(16.3) <.001
 Hypertension 35,940(90.5) 23,133(92.3) 12,807(87.4) <.001
 Chronic obstructive pulmonary disease 16,094(40.5) 12,377(49.4) 3,717(25.4) <.001
 Renal disease 13,169(33.2) 10,464(41.8) 2,705(18.5) <.001
 Stroke/TIA 3,820(9.6) 2,539(10.1) 1,281(8.7) <.001
 Myocardial infarction 12,405(31.2) 10,008(39.9) 2,397(16.4) <.001
 Cancer 4,167(10.5) 2,730(10.9) 1,437(9.8) <.001
 Valvular heart disease 16,437(41.4) 12,123(48.4) 4,314(29.4) <.001
CHA2DS2-VASc score, Mean(SD) 4.9(1.3) 5.4(1.2) 4.1(1.2) <.001
 Score<=2 1,356(3.4) 101(0.4) 1,255(8.6) <.001
 Score=3 4,122(10.4) 961(3.8) 3,161(21.6) <.001
 Score>=4 34,232(86.2) 23,992(95.8) 10,240(69.9) <.001
AF Burden at Baseline (days 31–60)
  Percent in AF, mean (SD) 6.43(18.69) 6.60(19.32) 6.13(17.56) 0.013
 Maximum duration, mean minutes (SD) 402.53 (2569.83) 467.72(3027.64) 291.08(1484.58) <.001

Baseline characteristics, co-morbidities, stratified by HF at baseline. Values are presented as n(%) unless otherwise specified.

HF: heart failure; SD: standard deviation; ICD: implantable cardioverter-defibrillator; CRT: cardiac resynchronization therapy; TIA: transient ischemic attack.